Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report

Low Dose ◽

Specific Antigen ◽

MP50-20 IMPACT OF ABIRATERONE ACETATE IN PROSTATE SPECIFIC ANTIGEN TRIAL UPDATE: EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN AND RADIOGRAPHIC DISEASE PROGRESSION IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.454 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Charles Ryan ◽

E. David Crawford ◽

Neal D Shore ◽

Willie Underwood ◽

Anil Londhe ◽

...

Keyword(s):

Prostate Cancer ◽

Disease Progression ◽

Low Dose ◽

Specific Antigen ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Radiographic Disease ◽

Dose Prednisone

Prostate-Specific Antigen Flare Phenomenon During 223Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2016.04.014 ◽

2016 ◽

Vol 14 (5) ◽

pp. e529-e533 ◽

Cited By ~ 12

Author(s):

Giuseppe De Vincentis ◽

Giulia Anna Follacchio ◽

Viviana Frantellizzi ◽

Mauro Liberatore ◽

Francesco Monteleone ◽

...

Keyword(s):

Prostate Cancer ◽

Case Report ◽

Specific Antigen ◽

Flare Phenomenon ◽

MP87-19 EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: THE RESULTS FROM IMPACT OF ABIRATERONE ACETATE IN PROSTATE-SPECIFIC ANTIGEN CORE STUDY

The Journal of Urology ◽

10.1016/j.juro.2015.02.1964 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Charles J. Ryan ◽

E. David Crawford ◽

Neal D. Shore ◽

Willie Underwood ◽

Jim Wang ◽

...

Keyword(s):

Prostate Cancer ◽

Low Dose ◽

Specific Antigen ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Core Study ◽

Dose Prednisone

Complete Biochemical (Prostate-specific Antigen) Response to Sipuleucel-T With Enzalutamide in Castration-resistant Prostate Cancer: A Case Report With Implications for Future Research

Urology ◽

10.1016/j.urology.2012.10.044 ◽

2013 ◽

Vol 81 (2) ◽

pp. 381-383 ◽

Cited By ~ 17

Author(s):

Julie N. Graff ◽

Charles G. Drake ◽

Tomasz M. Beer

Keyword(s):

Prostate Cancer ◽

Case Report ◽

Specific Antigen ◽

Future Research ◽

IMAAGEN trial safety and efficacy update: Effect of abiraterone acetate and low-dose prednisone on prostate-specific antigen and radiographic disease progression in patients with nonmetastatic castration-resistant prostate cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.5061 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 5061-5061 ◽

Cited By ~ 5

Author(s):

Charles J. Ryan ◽

E. David Crawford ◽

Neal D. Shore ◽

Willie Underwood ◽

Mary-Ellen Taplin ◽

...

Keyword(s):

Prostate Cancer ◽

Low Dose ◽

Specific Antigen ◽

Abiraterone Acetate ◽

Safety And Efficacy ◽

Castration Resistant ◽

Radiographic Disease ◽

Dose Prednisone

Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report

Oncology Letters ◽

10.3892/ol.2015.3940 ◽

2015 ◽

Vol 11 (1) ◽

pp. 713-716 ◽

Cited By ~ 4

Author(s):

CHIACHIEN JAKE WANG ◽

JAMES YING ◽

PAYAL KAPUR ◽

BRYAN WOHLFELD ◽

CLAUS ROEHRBORN ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Case Report ◽

Specific Antigen ◽

Detection of N,N-diacetyllactosamine (LacdiNAc) containing free prostate-specific antigen for early stage prostate cancer diagnostics and for identification of castration-resistant prostate cancer patients

Bioorganic & Medicinal Chemistry ◽

10.1016/j.bmc.2021.116156 ◽

2021 ◽

Vol 39 ◽

pp. 116156

Author(s):

Aniko Bertokova ◽

Tomas Bertok ◽

Eduard Jane ◽

Michal Hires ◽

Petra Ďubjaková ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Early Stage ◽

Specific Antigen ◽

Cancer Diagnostics ◽

Characterizing Prostate Specific Antigen Levels at Death in Patients with Metastatic Castration Resistant Prostate Cancer: Are we underutilizing imaging?

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.04.003 ◽

2021 ◽

Author(s):

Krishna Bikkasani ◽

Qian Qin ◽

Xiaobo Zhong ◽

Justin Lin ◽

Matthew D. Galsky ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Rapidly decreasing level of prostate-specific antigen during initial androgen deprivation therapy is a risk factor for early progression to castration-resistant prostate cancer

Medicine ◽

10.1097/md.0000000000007823 ◽

2017 ◽

Vol 96 (36) ◽

pp. e7823 ◽

Cited By ~ 2

Author(s):

Guangjie Ji ◽

Gang Song ◽

Cong Huang ◽

Shiming He ◽

Liqun Zhou

Keyword(s):

Prostate Cancer ◽

Risk Factor ◽

Androgen Deprivation Therapy ◽

Specific Antigen ◽

Androgen Deprivation ◽

Castration Resistant ◽

Early Progression

918 Prostate-specific antigen kinetics in patients with bone metastases from castration-resistant prostate cancer receiving zoledronic acid therapy

European Urology Supplements ◽

10.1016/s1569-9056(12)60915-4 ◽

2012 ◽

Vol 11 (1) ◽

pp. e918-e918a ◽

Cited By ~ 2

Author(s):

F. Saad ◽

J. Perez ◽

S. Segal ◽

J. Eastham

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Specific Antigen ◽

Acid Therapy ◽